Bookbuilding IPO | ₹2,206 Cr | Listed at BSE, NSE | Thu, Nov 3, 2022 - Mon, Nov 7, 2022
Global Health IPO is a book build issue of ₹2,205.57 crores. The issue is a combination of fresh issue of 1.49 crore shares aggregating to ₹500.00 crores and offer for sale of 5.08 crore shares aggregating to ₹1,705.57 crores.
Global Health IPO bidding started from Nov 3, 2022 and ended on Nov 7, 2022. The allotment for Global Health IPO was finalized on Nov 11, 2022. The shares got listed on BSE, NSE on Nov 16, 2022.
Global Health IPO price band is set at ₹336 per share. The lot size for an application is 44. The minimum amount of investment required by an retail is ₹14,784 (44 shares) (based on upper price). The lot size investment for sNII is 14 lots (616 shares), amounting to ₹2,06,976, and for bNII, it is 68 lots (2,992 shares), amounting to ₹10,05,312.
Kotak Mahindra Capital Co.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Global Health IPO RHP for detailed Information.
IPO Open
Thu, Nov 3, 2022
IPO Close
Mon, Nov 7, 2022
Issue Price
₹336 per share
Market Cap (Pre-IPO)
₹9,011.01 Cr
| IPO Date | 3 to 7 Nov, 2022 |
| Listed on | Wed, Nov 16, 2022 |
| Face Value | ₹2 per share |
| Price Band | ₹319 to ₹336 |
| Issue Price | ₹336 per share |
| Lot Size | 44 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 6,56,41,952 shares (agg. up to ₹2,206 Cr) |
| Fresh Issue | 1,48,80,952 shares (agg. up to ₹500 Cr) |
| Offer for Sale | 5,07,61,000 shares of ₹2 (agg. up to ₹1,706 Cr) |
| Share Holding Pre Issue | 25,33,03,930 shares |
| Share Holding Post Issue | 26,81,84,882 shares |
| BSE Script Code / NSE Symbol | 543654 / MEDANTA |
| ISIN | INE474Q01031 |
Global Health IPO offers total 6,56,41,952 shares. Out of which 3,28,20,975 (50.00%) allocated to QIB, 1,31,28,391 (20.00%) allocated to QIB (Ex- Anchor), 98,46,293 (15.00%) allocated to NII 2,29,74,684 (35.00%) allocated to RII and 1,96,92,584 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Max Allottees |
|---|---|---|
| QIB Shares Offered | 3,28,20,975 (50.00%) | NA |
| − Anchor Investor Shares Offered | 1,96,92,584 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 1,31,28,391 (20.00%) | NA |
| NII (HNI) Shares Offered | 98,46,293 (15.00%) | NA |
| − bNII > ₹10L | 65,64,196 (10.00%) | 10,656 |
| − sNII < ₹10L | 32,82,097 (5.00%) | 5,328 |
| Retail Shares Offered | 2,29,74,684 (35.00%) | 5,22,151 |
| Total Shares Offered | 6,56,41,952 (100.00%) |
Investors can bid for a minimum of 44 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 44 | ₹14,784 |
| Retail (Max) | 13 | 572 | ₹1,92,192 |
| S-HNI (Min) | 14 | 616 | ₹2,06,976 |
| S-HNI (Max) | 67 | 2,948 | ₹9,90,528 |
| B-HNI (Min) | 68 | 2,992 | ₹10,05,312 |
Global Health IPO raises ₹661.67 crore from anchor investors. Global Health IPO Anchor bid date is November 2, 2022.
📝 Anchor Investors Letter (PDF)
| Bid Date | Wed, Nov 2, 2022 |
| Shares Offered | 1,96,92,584 |
| Anchor Portion (₹ Cr.) | 661.67 |
| Anchor lock-in period end date for 50% shares (30 Days) | Sun, Dec 11, 2022 |
| Anchor lock-in period end date for remaining shares (90 Days) | Thu, Feb 9, 2023 |
Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.
Global Health Limited have a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow) under the "Medanta" brand. The company established "The Medanta Institutional Tissue Repository" in 2017 to promote biomarker and other tissue-based research.
In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs. 14,805.71 million, Rs. 14,178.41 million, Rs. 21,003.95 million, Rs. 4,732.10 million and Rs. 5,960.89 226 million, respectively, and had EBITDA of Rs. 2,304.54 million, Rs. 2,228.52 million, Rs. 4,897.57 million, Rs. 1,057.69 million and Rs. 1,416.46 million, respectively.
As of June 30, 2022, the company provide healthcare services in over 30 medical specialities and engage over 1,300 doctors led by experienced department heads, spanning an area of 4.7 million sq. ft., the operational hospitals have 2,467 installed beds.
Global Health Limited's hospital at Gurugram was ranked as the best private hospital in India for three consecutive years in 2020, 2021 and 2022, and was the only Indian private hospital to be featured in the list of top 200 global hospitals in 2021 and was featured in the list of top 250 global hospitals in 2022 by Newsweek
Competitive Strengths:
| Period Ended | 30 Jun 2022 | 31 Mar 2022 | 31 Mar 2021 | 30 Jun 2020 | 31 Mar 2020 |
|---|---|---|---|---|---|
| Assets | 3,221.94 | 3,145.52 | 2,694.11 | 2,855.11 | 2,666.29 |
| Total Income | 626.54 | 2,205.82 | 1,478.16 | 491.58 | 1,544.27 |
| Profit After Tax | 58.71 | 196.20 | 28.81 | 41.76 | 36.33 |
| NET Worth | 1,675.55 | 1,616.01 | 1,382.34 | 1,425.38 | 1,349.54 |
| Reserves and Surplus | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Borrowing | 794.45 | 837.86 | 644.60 | 725.07 | 621.94 |
| Amount in ₹ Crore | |||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in two of our Subsidiaries, GHPPL and MHPL, in the form of debt or equity for repayment/prepayment of borrowings, in full or part, of such Subsidiaries | 375.00 |
| 2 | General corporate purposes | 101.70 |
| KPI | |
|---|---|
| ROE | 13.1 |
| ROCE | 16.3 |
| Debt/Equity | 0.50 |
| RoNW | 12.14 |
| PAT Margin | 9.00% |
| EBITDA Margin | 21.92% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 7.78 | |
| P/E (x) | 38.36 | |
| Promoter Holding | 35% | 33% |
| Market Cap | ₹9,011.01 Cr. |
The Global Health IPO is subscribed 9.58 times on November 7, 2022 7:00:00 PM (Day 3). The public issue subscribed 0.88 times in the retail category, 28.64 times in the QIB category, and 4.02 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 28.64 | 1,35,24,905 | 38,73,58,840 |
| NII | 4.02 | 99,65,248 | 4,00,55,620 |
| bNII (bids above ₹10L) | 5.16 | 66,43,498 | 3,42,97,032 |
| sNII (bids below ₹10L) | 1.73 | 33,21,750 | 57,58,588 |
| Retail | 0.88 | 2,32,52,244 | 2,05,71,188 |
| Total | 9.58 | 4,67,42,397 | 44,79,85,648 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Book Running Lead Managers’ fees and commissions (including underwriting commission, brokerage and selling commission) | 0.59 |
| 2 | Commission/processing fee for SCSBs, Sponsor Banks and Bankers to the Offer. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | 0.05 |
| 3 | Fees payable to the Registrar to the Offer | 0.01 |
| 4 | Fees payable to the other advisors to the Offer | 0.06 |
| 5 | Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses | 0.06 |
| 6 | Printing and stationery | 0.03 |
| 7 | Advertising and marketing expenses | 0.09 |
| 8 | Fee payable to legal counsels | 0.09 |
| 9 | Miscellaneous | 0.05 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹336.00 | ₹336.00 |
| Open | ₹398.15 | ₹401.00 |
| Low | ₹391.05 | ₹390.55 |
| High | ₹424.90 | ₹424.65 |
| Last Trade | ₹415.65 | ₹415.30 |
Lead Manager Reports
Global Health IPO is a main-board IPO of 6,56,41,952 equity shares of the face value of ₹2 aggregating up to ₹2,206 Crores. The issue is priced at ₹336 per share. The minimum order quantity is 44.
The IPO opens on Thu, Nov 3, 2022, and closes on Mon, Nov 7, 2022.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Global Health IPO using UPI as a payment gateway. Zerodha customers can apply in Global Health IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Global Health IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Global Health IPO opens on Thu, Nov 3, 2022 and closes on Mon, Nov 7, 2022.
Global Health IPO lot size is 44, and the minimum amount required for application is ₹14,784.
You can apply in Global Health IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Global Health IPO will be done on Friday, November 11, 2022, and the allotted shares will be credited to your demat account by Tue, Nov 15, 2022. Check the Global Health IPO allotment status.
The Global Health IPO listing date is on Wed, Nov 16, 2022.
